TY - JOUR AU - Dowling, R. J. AU - Goodwin, P. J. AU - Stambolic, V. PY - 2011 DA - 2011// TI - Understanding the benefit of metformin use in cancer treatment JO - BMC Med VL - 9 UR - https://doi.org/10.1186/1741-7015-9-33 DO - 10.1186/1741-7015-9-33 ID - Dowling2011 ER - TY - JOUR AU - Hundal, H. S. AU - Ramlal, T. AU - Reyes, R. PY - 1992 DA - 1992// TI - Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in l6 muscle cells JO - Endocrinology VL - 131 ID - Hundal1992 ER - TY - JOUR AU - Li, X. AU - Zhang, N. AU - Li, Y. PY - 2011 DA - 2011// TI - Effects of metformin and rosiglitazone on peripheral insulin resistance and beta-cell function in obesity: a double-blind, randomized, controlled study JO - J Int Med Res VL - 39 UR - https://doi.org/10.1177/147323001103900203 DO - 10.1177/147323001103900203 ID - Li2011 ER - TY - JOUR AU - Witters, L. A. PY - 2001 DA - 2001// TI - The blooming of the french lilac JO - J Clin Invest VL - 108 UR - https://doi.org/10.1172/JCI14178 DO - 10.1172/JCI14178 ID - Witters2001 ER - TY - JOUR AU - Sahra, I. B. AU - Marchand-Brustel, Y. AU - Tanti, J. F. PY - 2010 DA - 2010// TI - Metformin in cancer therapy: a new perspective for an old antidiabetic drug? JO - Mol Cancer Ther VL - 9 UR - https://doi.org/10.1158/1535-7163.MCT-09-1186 DO - 10.1158/1535-7163.MCT-09-1186 ID - Sahra2010 ER - TY - JOUR AU - Gonzalez-Angulo, A. M. AU - Meric-Bernstam, F. PY - 2010 DA - 2010// TI - Metformin: a therapeutic opportunity in breast cancer JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-09-1805 DO - 10.1158/1078-0432.CCR-09-1805 ID - Gonzalez-Angulo2010 ER - TY - JOUR AU - Tomic, T. AU - Botton, T. AU - Cerezo, M. PY - 2011 DA - 2011// TI - Metformin inhibits melanoma development through autophagy and apoptosis mechanisms JO - Cell Death Dis VL - 2 UR - https://doi.org/10.1038/cddis.2011.86 DO - 10.1038/cddis.2011.86 ID - Tomic2011 ER - TY - JOUR AU - Salani, B. AU - Maffioli, S. AU - Hamoudane, M. PY - 2012 DA - 2012// TI - Caveolin-1 is essential for metformin inhibitory effect on igf1 action in non-small-cell lung cancer cells JO - FASEB J VL - 26 UR - https://doi.org/10.1096/fj.11-192088 DO - 10.1096/fj.11-192088 ID - Salani2012 ER - TY - JOUR AU - Quinn, B. J. AU - Dallos, M. AU - Kitagawa, H. PY - 2013 DA - 2013// TI - Inhibition of lung tumorigenesis by metformin is associated with decreased plasma igf-i and diminished receptor tyrosine kinase signaling JO - Cancer Prev Res (Phila) VL - 6 UR - https://doi.org/10.1158/1940-6207.CAPR-13-0058-T DO - 10.1158/1940-6207.CAPR-13-0058-T ID - Quinn2013 ER - TY - JOUR AU - Feng, Y. AU - Ke, C. AU - Tang, Q. PY - 2014 DA - 2014// TI - Metformin promotes autophagy and apoptosis in esophageal squamous cell carcinoma by downregulating stat3 signaling JO - Cell Death Dis VL - 5 UR - https://doi.org/10.1038/cddis.2014.59 DO - 10.1038/cddis.2014.59 ID - Feng2014 ER - TY - JOUR AU - Colquhoun, A. J. AU - Venier, N. A. AU - Vandersluis, A. D. PY - 2012 DA - 2012// TI - Metformin enhances the antiproliferative and apoptotic effect of bicalutamide in prostate cancer JO - Prostate Cancer Prostatic Dis VL - 15 UR - https://doi.org/10.1038/pcan.2012.16 DO - 10.1038/pcan.2012.16 ID - Colquhoun2012 ER - TY - JOUR AU - Li, L. AU - Han, R. AU - Xiao, H. PY - 2014 DA - 2014// TI - Metformin sensitizes egfr-tki-resistant human lung cancer cells in vitro and in vivo through inhibition of il-6 signaling and emt reversal JO - Clin Cancer Res VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2613 DO - 10.1158/1078-0432.CCR-13-2613 ID - Li2014 ER - TY - JOUR AU - Blandino, G. AU - Valerio, M. AU - Cioce, M. PY - 2012 DA - 2012// TI - Metformin elicits anticancer effects through the sequential modulation of dicer and c-myc JO - Nat Commun VL - 3 UR - https://doi.org/10.1038/ncomms1859 DO - 10.1038/ncomms1859 ID - Blandino2012 ER - TY - JOUR AU - Xu, Y. AU - Lu, S. PY - 2013 DA - 2013// TI - Metformin inhibits esophagus cancer proliferation through upregulation of usp7 JO - Cell Physiol Biochem VL - 32 UR - https://doi.org/10.1159/000354517 DO - 10.1159/000354517 ID - Xu2013 ER - TY - JOUR AU - Algire, C. AU - Amrein, L. AU - Zakikhani, M. PY - 2010 DA - 2010// TI - Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase JO - Endocr Relat Cancer VL - 17 UR - https://doi.org/10.1677/ERC-09-0252 DO - 10.1677/ERC-09-0252 ID - Algire2010 ER - TY - JOUR AU - Niehr, F. AU - Euw, E. AU - Attar, N. PY - 2011 DA - 2011// TI - Combination therapy with vemurafenib (plx4032/rg7204) and metformin in melanoma cell lines with distinct driver mutations JO - J Transl Med VL - 9 UR - https://doi.org/10.1186/1479-5876-9-76 DO - 10.1186/1479-5876-9-76 ID - Niehr2011 ER - TY - JOUR AU - Han, G. AU - Gong, H. AU - Wang, Y. PY - 2015 DA - 2015// TI - Ampk/mtor-mediated inhibition of survivin partly contributes to metformin-induced apoptosis in human gastric cancer cell JO - Cancer Biol Ther VL - 16 UR - https://doi.org/10.4161/15384047.2014.987021 DO - 10.4161/15384047.2014.987021 ID - Han2015 ER - TY - JOUR AU - Zhao, D. AU - Long, X. D. AU - Lu, T. F. PY - 2015 DA - 2015// TI - Metformin decreases il-22 secretion to suppress tumor growth in an orthotopic mouse model of hepatocellular carcinoma JO - Int J Cancer VL - 136 UR - https://doi.org/10.1002/ijc.29305 DO - 10.1002/ijc.29305 ID - Zhao2015 ER - TY - JOUR AU - Zi, F. M. AU - He, J. S. AU - Li, Y. PY - 2014 DA - 2014// TI - Metformin displays anti-myeloma activity and synergistic effect with dexamethasone in in vitro and in vivo xenograft models JO - Cancer Lett VL - 356 UR - https://doi.org/10.1016/j.canlet.2014.09.050 DO - 10.1016/j.canlet.2014.09.050 ID - Zi2014 ER - TY - JOUR AU - Qu, C. AU - Zhang, W. AU - Zheng, G. PY - 2014 DA - 2014// TI - Metformin reverses multidrug resistance and epithelial-mesenchymal transition (emt) via activating amp-activated protein kinase (ampk) in human breast cancer cells JO - Mol Cell Biochem VL - 386 UR - https://doi.org/10.1007/s11010-013-1845-x DO - 10.1007/s11010-013-1845-x ID - Qu2014 ER - TY - JOUR AU - Lengyel, E. AU - Litchfield, L. M. AU - Mitra, A. K. PY - 2015 DA - 2015// TI - Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models JO - Am J Obstet Gynecol VL - 212 UR - https://doi.org/10.1016/j.ajog.2014.10.026 DO - 10.1016/j.ajog.2014.10.026 ID - Lengyel2015 ER - TY - JOUR AU - Uehara, T. AU - Mitsuhashi, A. AU - Tsuruoka, N. PY - 2015 DA - 2015// TI - Metformin potentiates the anticancer effects of cisplatin under normoxic conditions in vitro JO - Oncol Rep VL - 33 ID - Uehara2015 ER - TY - JOUR AU - Fasih, A. AU - Elbaz, H. A. AU - Huttemann, M. PY - 2014 DA - 2014// TI - Radiosensitization of pancreatic cancer cells by metformin through the ampk pathway JO - Radiat Res VL - 182 UR - https://doi.org/10.1667/RR13568.1 DO - 10.1667/RR13568.1 ID - Fasih2014 ER - TY - JOUR AU - Zhang, Y. AU - Storr, S. J. AU - Johnson, K. PY - 2014 DA - 2014// TI - Involvement of metformin and ampk in the radioresponse and prognosis of luminal versus basal-like breast cancer treated with radiotherapy JO - Oncotarget VL - 5 UR - https://doi.org/10.18632/oncotarget.2683 DO - 10.18632/oncotarget.2683 ID - Zhang2014 ER - TY - JOUR AU - Nangia-Makker, P. AU - Yu, Y. AU - Vasudevan, A. PY - 2014 DA - 2014// TI - Metformin: a potential therapeutic agent for recurrent colon cancer JO - PLoS ONE VL - 9 UR - https://doi.org/10.1371/journal.pone.0084369 DO - 10.1371/journal.pone.0084369 ID - Nangia-Makker2014 ER - TY - JOUR AU - Barriere, G. AU - Tartary, M. AU - Rigaud, M. PY - 2013 DA - 2013// TI - Metformin: a rising star to fight the epithelial mesenchymal transition in oncology JO - Anticancer Agents Med Chem VL - 13 UR - https://doi.org/10.2174/1871520611313020018 DO - 10.2174/1871520611313020018 ID - Barriere2013 ER - TY - JOUR AU - Shaw, R. J. AU - Lamia, K. A. AU - Vasquez, D. PY - 2005 DA - 2005// TI - The kinase lkb1 mediates glucose homeostasis in liver and therapeutic effects of metformin JO - Science VL - 310 UR - https://doi.org/10.1126/science.1120781 DO - 10.1126/science.1120781 ID - Shaw2005 ER - TY - JOUR AU - Hardie, D. G. PY - 2007 DA - 2007// TI - Amp-activated/snf1 protein kinases: conserved guardians of cellular energy JO - Nat Rev Mol Cell Biol VL - 8 UR - https://doi.org/10.1038/nrm2249 DO - 10.1038/nrm2249 ID - Hardie2007 ER - TY - JOUR AU - Vazquez-Martin, A. AU - Lopez-Bonet, E. AU - Oliveras-Ferraros, C. PY - 2009 DA - 2009// TI - Mitotic kinase dynamics of the active form of ampk (phospho-ampkalphathr172) in human cancer cells JO - Cell Cycle VL - 8 UR - https://doi.org/10.4161/cc.8.5.7787 DO - 10.4161/cc.8.5.7787 ID - Vazquez-Martin2009 ER - TY - JOUR AU - Vakana, E. AU - Altman, J. K. AU - Glaser, H. PY - 2011 DA - 2011// TI - Antileukemic effects of ampk activators on bcr-abl-expressing cells JO - Blood VL - 118 UR - https://doi.org/10.1182/blood-2011-01-332783 DO - 10.1182/blood-2011-01-332783 ID - Vakana2011 ER - TY - JOUR AU - Algire, C. AU - Amrein, L. AU - Bazile, M. PY - 2011 DA - 2011// TI - Diet and tumor lkb1 expression interact to determine sensitivity to anti-neoplastic effects of metformin in vivo JO - Oncogene VL - 30 UR - https://doi.org/10.1038/onc.2010.483 DO - 10.1038/onc.2010.483 ID - Algire2011 ER - TY - JOUR AU - Grimaldi, C. AU - Chiarini, F. AU - Tabellini, G. PY - 2012 DA - 2012// TI - Amp-dependent kinase/mammalian target of rapamycin complex 1 signaling in t-cell acute lymphoblastic leukemia: therapeutic implications JO - Leukemia VL - 26 UR - https://doi.org/10.1038/leu.2011.269 DO - 10.1038/leu.2011.269 ID - Grimaldi2012 ER - TY - JOUR AU - Cazzaniga, M. AU - Bonanni, B. AU - Guerrieri-Gonzaga, A. PY - 2009 DA - 2009// TI - Is it time to test metformin in breast cancer clinical trials? JO - Cancer Epidemiol Biomarkers Prev VL - 18 UR - https://doi.org/10.1158/1055-9965.EPI-08-0871 DO - 10.1158/1055-9965.EPI-08-0871 ID - Cazzaniga2009 ER - TY - JOUR AU - Kisfalvi, K. AU - Eibl, G. AU - Sinnett-Smith, J. PY - 2009 DA - 2009// TI - Metformin disrupts crosstalk between g protein-coupled receptor and insulin receptor signaling systems and inhibits pancreatic cancer growth JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-09-0418 DO - 10.1158/0008-5472.CAN-09-0418 ID - Kisfalvi2009 ER - TY - JOUR AU - Klubo-Gwiezdzinska, J. AU - Jensen, K. AU - Costello, J. PY - 2012 DA - 2012// TI - Metformin inhibits growth and decreases resistance to anoikis in medullary thyroid cancer cells JO - Endocr Relat Cancer VL - 19 UR - https://doi.org/10.1530/ERC-12-0046 DO - 10.1530/ERC-12-0046 ID - Klubo-Gwiezdzinska2012 ER - TY - JOUR AU - Shi, W. Y. AU - Xiao, D. AU - Wang, L. PY - 2012 DA - 2012// TI - Therapeutic metformin/ampk activation blocked lymphoma cell growth via inhibition of mtor pathway and induction of autophagy JO - Cell Death Dis VL - 3 UR - https://doi.org/10.1038/cddis.2012.13 DO - 10.1038/cddis.2012.13 ID - Shi2012 ER - TY - JOUR AU - Kim, H. G. AU - Hien, T. T. AU - Han, E. H. PY - 2011 DA - 2011// TI - Metformin inhibits p-glycoprotein expression via the nf-kappab pathway and cre transcriptional activity through ampk activation JO - Br J Pharmacol VL - 162 UR - https://doi.org/10.1111/j.1476-5381.2010.01101.x DO - 10.1111/j.1476-5381.2010.01101.x ID - Kim2011 ER - TY - JOUR AU - Sahra, I. B. AU - Laurent, K. AU - Loubat, A. PY - 2008 DA - 2008// TI - The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin d1 level JO - Oncogene VL - 27 UR - https://doi.org/10.1038/sj.onc.1211024 DO - 10.1038/sj.onc.1211024 ID - Sahra2008 ER - TY - JOUR AU - Sahra, I. B. AU - Regazzetti, C. AU - Robert, G. PY - 2011 DA - 2011// TI - Metformin, independent of ampk, induces mtor inhibition and cell-cycle arrest through redd1 JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-1769 DO - 10.1158/0008-5472.CAN-10-1769 ID - Sahra2011 ER - TY - JOUR AU - Yasmeen, A. AU - Beauchamp, M. C. AU - Piura, E. PY - 2011 DA - 2011// TI - Induction of apoptosis by metformin in epithelial ovarian cancer: involvement of the bcl-2 family proteins JO - Gynecol Oncol VL - 121 UR - https://doi.org/10.1016/j.ygyno.2011.02.021 DO - 10.1016/j.ygyno.2011.02.021 ID - Yasmeen2011 ER - TY - JOUR AU - Muaddi, H. AU - Chowdhury, S. AU - Vellanki, R. PY - 2013 DA - 2013// TI - Contributions of ampk and p53 dependent signaling to radiation response in the presence of metformin JO - Radiother Oncol VL - 108 UR - https://doi.org/10.1016/j.radonc.2013.06.014 DO - 10.1016/j.radonc.2013.06.014 ID - Muaddi2013 ER - TY - JOUR AU - Arai, M. AU - Uchiba, M. AU - Komura, H. PY - 2010 DA - 2010// TI - Metformin, an antidiabetic agent, suppresses the production of tumor necrosis factor and tissue factor by inhibiting early growth response factor-1 expression in human monocytes in vitro JO - J Pharmacol Exp Ther VL - 334 UR - https://doi.org/10.1124/jpet.109.164970 DO - 10.1124/jpet.109.164970 ID - Arai2010 ER - TY - JOUR AU - Gou, S. AU - Cui, P. AU - Li, X. PY - 2013 DA - 2013// TI - Low concentrations of metformin selectively inhibit cd133(+) cell proliferation in pancreatic cancer and have anticancer action JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0063969 DO - 10.1371/journal.pone.0063969 ID - Gou2013 ER - TY - JOUR AU - Zoncu, R. AU - Efeyan, A. AU - Sabatini, D. M. PY - 2011 DA - 2011// TI - Mtor: from growth signal integration to cancer, diabetes and ageing JO - Nat Rev Mol Cell Biol VL - 12 UR - https://doi.org/10.1038/nrm3025 DO - 10.1038/nrm3025 ID - Zoncu2011 ER - TY - JOUR AU - Yecies, J. L. AU - Manning, B. D. PY - 2011 DA - 2011// TI - Mtor links oncogenic signaling to tumor cell metabolism JO - J Mol Med (Berl) VL - 89 UR - https://doi.org/10.1007/s00109-011-0726-6 DO - 10.1007/s00109-011-0726-6 ID - Yecies2011 ER - TY - JOUR AU - Cheaib, B. AU - Auguste, A. AU - Leary, A. PY - 2015 DA - 2015// TI - The pi3 k/akt/mtor pathway in ovarian cancer: therapeutic opportunities and challenges JO - Chin J Cancer VL - 34 UR - https://doi.org/10.5732/cjc.014.10289 DO - 10.5732/cjc.014.10289 ID - Cheaib2015 ER - TY - JOUR AU - Zhou, W. AU - Marcus, A. I. AU - Vertino, P. M. PY - 2013 DA - 2013// TI - Dysregulation of mtor activity through lkb1 inactivation JO - Chin J Cancer VL - 32 UR - https://doi.org/10.5732/cjc.013.10086 DO - 10.5732/cjc.013.10086 ID - Zhou2013 ER - TY - JOUR AU - Hay, N. AU - Sonenberg, N. PY - 2004 DA - 2004// TI - Upstream and downstream of mtor JO - Genes Dev VL - 18 UR - https://doi.org/10.1101/gad.1212704 DO - 10.1101/gad.1212704 ID - Hay2004 ER - TY - JOUR AU - Dancey, J. PY - 2010 DA - 2010// TI - Mtor signaling and drug development in cancer JO - Nat Rev Clin Oncol VL - 7 UR - https://doi.org/10.1038/nrclinonc.2010.21 DO - 10.1038/nrclinonc.2010.21 ID - Dancey2010 ER - TY - JOUR AU - Klumpen, H. J. AU - Beijnen, J. H. AU - Gurney, H. PY - 2010 DA - 2010// TI - Inhibitors of mtor JO - Oncologist VL - 15 UR - https://doi.org/10.1634/theoncologist.2010-0196 DO - 10.1634/theoncologist.2010-0196 ID - Klumpen2010 ER - TY - JOUR AU - Nahta, R. AU - O’Regan, R. M. PY - 2010 DA - 2010// TI - Evolving strategies for overcoming resistance to her2-directed therapy: targeting the pi3k/akt/mtor pathway JO - Clin Breast Cancer VL - 10 UR - https://doi.org/10.3816/CBC.2010.s.015 DO - 10.3816/CBC.2010.s.015 ID - Nahta2010 ER - TY - JOUR AU - Sheri, A. AU - Martin, L. A. AU - Johnston, S. PY - 2010 DA - 2010// TI - Targeting endocrine resistance: is there a role for mtor inhibition? JO - Clin Breast Cancer VL - 10 UR - https://doi.org/10.3816/CBC.2010.s.016 DO - 10.3816/CBC.2010.s.016 ID - Sheri2010 ER - TY - JOUR AU - Wullschleger, S. AU - Loewith, R. AU - Hall, M. N. PY - 2006 DA - 2006// TI - Tor signaling in growth and metabolism JO - Cell VL - 124 UR - https://doi.org/10.1016/j.cell.2006.01.016 DO - 10.1016/j.cell.2006.01.016 ID - Wullschleger2006 ER - TY - JOUR AU - Inoki, K. AU - Corradetti, M. N. AU - Guan, K. L. PY - 2005 DA - 2005// TI - Dysregulation of the tsc-mtor pathway in human disease JO - Nat Genet VL - 37 UR - https://doi.org/10.1038/ng1494 DO - 10.1038/ng1494 ID - Inoki2005 ER - TY - JOUR AU - Shaw, R. J. AU - Cantley, L. C. PY - 2006 DA - 2006// TI - Ras, pi(3)k and mtor signalling controls tumour cell growth JO - Nature VL - 441 UR - https://doi.org/10.1038/nature04869 DO - 10.1038/nature04869 ID - Shaw2006 ER - TY - JOUR AU - Holz, M. K. AU - Ballif, B. A. AU - Gygi, S. P. PY - 2005 DA - 2005// TI - Mtor and s6k1 mediate assembly of the translation preinitiation complex through dynamic protein interchange and ordered phosphorylation events JO - Cell VL - 123 UR - https://doi.org/10.1016/j.cell.2005.10.024 DO - 10.1016/j.cell.2005.10.024 ID - Holz2005 ER - TY - JOUR AU - Zakikhani, M. AU - Dowling, R. AU - Fantus, I. G. PY - 2006 DA - 2006// TI - Metformin is an amp kinase-dependent growth inhibitor for breast cancer cells JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-1500 DO - 10.1158/0008-5472.CAN-06-1500 ID - Zakikhani2006 ER - TY - JOUR AU - Dowling, R. J. AU - Zakikhani, M. AU - Fantus, I. G. PY - 2007 DA - 2007// TI - Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-07-2310 DO - 10.1158/0008-5472.CAN-07-2310 ID - Dowling2007 ER - TY - JOUR AU - Green, A. S. AU - Chapuis, N. AU - Maciel, T. T. PY - 2010 DA - 2010// TI - The lkb1/ampk signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mtor-dependent oncogenic mrna translation JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2010-02-269837 DO - 10.1182/blood-2010-02-269837 ID - Green2010 ER - TY - JOUR AU - Pan, J. AU - Chen, C. AU - Jin, Y. PY - 2012 DA - 2012// TI - Differential impact of structurally different anti-diabetic drugs on proliferation and chemosensitivity of acute lymphoblastic leukemia cells JO - Cell Cycle VL - 11 UR - https://doi.org/10.4161/cc.20770 DO - 10.4161/cc.20770 ID - Pan2012 ER - TY - JOUR AU - Morgillo, F. AU - Sasso, F. C. AU - Della Corte, C. M. PY - 2013 DA - 2013// TI - Synergistic effects of metformin treatment in combination with gefitinib, a selective egfr tyrosine kinase inhibitor, in lkb1 wild-type nsclc cell lines JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-12-2777 DO - 10.1158/1078-0432.CCR-12-2777 ID - Morgillo2013 ER - TY - JOUR AU - Memmott, R. M. AU - Mercado, J. R. AU - Maier, C. R. PY - 2010 DA - 2010// TI - Metformin prevents tobacco carcinogen-induced lung tumorigenesis JO - Cancer Prev Res (Phila) VL - 3 UR - https://doi.org/10.1158/1940-6207.CAPR-10-0055 DO - 10.1158/1940-6207.CAPR-10-0055 ID - Memmott2010 ER - TY - JOUR AU - Rocha, G. Z. AU - Dias, M. M. AU - Ropelle, E. R. PY - 2011 DA - 2011// TI - Metformin amplifies chemotherapy-induced ampk activation and antitumoral growth JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-10-2243 DO - 10.1158/1078-0432.CCR-10-2243 ID - Rocha2011 ER - TY - JOUR AU - Deng, X. S. AU - Wang, S. AU - Deng, A. PY - 2012 DA - 2012// TI - Metformin targets stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers JO - Cell Cycle VL - 11 UR - https://doi.org/10.4161/cc.11.2.18813 DO - 10.4161/cc.11.2.18813 ID - Deng2012 ER - TY - JOUR AU - Vitale-Cross, L. AU - Molinolo, A. A. AU - Martin, D. PY - 2012 DA - 2012// TI - Metformin prevents the development of oral squamous cell carcinomas from carcinogen-induced premalignant lesions JO - Cancer Prev Res (Phila) VL - 5 UR - https://doi.org/10.1158/1940-6207.CAPR-11-0502 DO - 10.1158/1940-6207.CAPR-11-0502 ID - Vitale-Cross2012 ER - TY - JOUR AU - Cho, S. W. AU - Yi, K. H. AU - Han, S. K. PY - 2014 DA - 2014// TI - Therapeutic potential of metformin in papillary thyroid cancer in vitro and in vivo JO - Mol Cell Endocrinol VL - 393 UR - https://doi.org/10.1016/j.mce.2014.05.021 DO - 10.1016/j.mce.2014.05.021 ID - Cho2014 ER - TY - JOUR AU - Checkley, L. A. AU - Rho, O. AU - Angel, J. M. PY - 2014 DA - 2014// TI - Metformin inhibits skin tumor promotion in overweight and obese mice JO - Cancer Prev Res (Phila) VL - 7 UR - https://doi.org/10.1158/1940-6207.CAPR-13-0110 DO - 10.1158/1940-6207.CAPR-13-0110 ID - Checkley2014 ER - TY - JOUR AU - Shaw, R. J. AU - Bardeesy, N. AU - Manning, B. D. PY - 2004 DA - 2004// TI - The lkb1 tumor suppressor negatively regulates mtor signaling JO - Cancer Cell VL - 6 UR - https://doi.org/10.1016/j.ccr.2004.06.007 DO - 10.1016/j.ccr.2004.06.007 ID - Shaw2004 ER - TY - JOUR AU - Vazquez-Martin, A. AU - Oliveras-Ferraros, C. AU - Barco, S. PY - 2009 DA - 2009// TI - The antidiabetic drug metformin: a pharmaceutical ampk activator to overcome breast cancer resistance to her2 inhibitors while decreasing risk of cardiomyopathy JO - Ann Oncol VL - 20 UR - https://doi.org/10.1093/annonc/mdn758 DO - 10.1093/annonc/mdn758 ID - Vazquez-Martin2009 ER - TY - JOUR AU - Inoki, K. AU - Zhu, T. AU - Guan, K. L. PY - 2003 DA - 2003// TI - Tsc2 mediates cellular energy response to control cell growth and survival JO - Cell VL - 115 UR - https://doi.org/10.1016/S0092-8674(03)00929-2 DO - 10.1016/S0092-8674(03)00929-2 ID - Inoki2003 ER - TY - JOUR AU - Gwinn, D. M. AU - Shackelford, D. B. AU - Egan, D. F. PY - 2008 DA - 2008// TI - Ampk phosphorylation of raptor mediates a metabolic checkpoint JO - Mol Cell VL - 30 UR - https://doi.org/10.1016/j.molcel.2008.03.003 DO - 10.1016/j.molcel.2008.03.003 ID - Gwinn2008 ER - TY - JOUR AU - Engelman, J. A. AU - Cantley, L. C. PY - 2010 DA - 2010// TI - Chemoprevention meets glucose control JO - Cancer Prev Res (Phila) VL - 3 UR - https://doi.org/10.1158/1940-6207.CAPR-10-0178 DO - 10.1158/1940-6207.CAPR-10-0178 ID - Engelman2010 ER - TY - JOUR AU - Memmott, R. M. AU - Dennis, P. A. PY - 2009 DA - 2009// TI - Lkb1 and mammalian target of rapamycin as predictive factors for the anticancer efficacy of metformin JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2009.25.3963 DO - 10.1200/JCO.2009.25.3963 ID - Memmott2009 ER - TY - JOUR AU - Kalender, A. AU - Selvaraj, A. AU - Kim, S. Y. PY - 2010 DA - 2010// TI - Metformin, independent of ampk, inhibits mtorc1 in a rag gtpase-dependent manner JO - Cell Metab VL - 11 UR - https://doi.org/10.1016/j.cmet.2010.03.014 DO - 10.1016/j.cmet.2010.03.014 ID - Kalender2010 ER - TY - JOUR AU - Pollak, M. PY - 2008 DA - 2008// TI - Insulin and insulin-like growth factor signalling in neoplasia JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2536 DO - 10.1038/nrc2536 ID - Pollak2008 ER - TY - JOUR AU - Baserga, R. AU - Peruzzi, F. AU - Reiss, K. PY - 2003 DA - 2003// TI - The igf-1 receptor in cancer biology JO - Int J Cancer VL - 107 UR - https://doi.org/10.1002/ijc.11487 DO - 10.1002/ijc.11487 ID - Baserga2003 ER - TY - JOUR AU - Manning, B. D. AU - Cantley, L. C. PY - 2007 DA - 2007// TI - Akt/pkb signaling: navigating downstream JO - Cell VL - 129 UR - https://doi.org/10.1016/j.cell.2007.06.009 DO - 10.1016/j.cell.2007.06.009 ID - Manning2007 ER - TY - JOUR AU - Johnson, G. L. AU - Lapadat, R. PY - 2002 DA - 2002// TI - Mitogen-activated protein kinase pathways mediated by erk, jnk, and p38 protein kinases JO - Science VL - 298 UR - https://doi.org/10.1126/science.1072682 DO - 10.1126/science.1072682 ID - Johnson2002 ER - TY - JOUR AU - Lopez, T. AU - Hanahan, D. PY - 2002 DA - 2002// TI - Elevated levels of igf-1 receptor convey invasive and metastatic capability in a mouse model of pancreatic islet tumorigenesis JO - Cancer Cell VL - 1 UR - https://doi.org/10.1016/S1535-6108(02)00055-7 DO - 10.1016/S1535-6108(02)00055-7 ID - Lopez2002 ER - TY - JOUR AU - Jones, R. A. AU - Campbell, C. I. AU - Gunther, E. J. PY - 2007 DA - 2007// TI - Transgenic overexpression of igf-ir disrupts mammary ductal morphogenesis and induces tumor formation JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1209955 DO - 10.1038/sj.onc.1209955 ID - Jones2007 ER - TY - JOUR AU - McCampbell, A. S. AU - Broaddus, R. R. AU - Loose, D. S. PY - 2006 DA - 2006// TI - Overexpression of the insulin-like growth factor i receptor and activation of the akt pathway in hyperplastic endometrium JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-06-0912 DO - 10.1158/1078-0432.CCR-06-0912 ID - McCampbell2006 ER - TY - JOUR AU - Wang, C. F. AU - Zhang, G. AU - Zhao, L. J. PY - 2013 DA - 2013// TI - Overexpression of the insulin receptor isoform a promotes endometrial carcinoma cell growth JO - PLoS ONE VL - 8 UR - https://doi.org/10.1371/journal.pone.0069001 DO - 10.1371/journal.pone.0069001 ID - Wang2013 ER - TY - JOUR AU - Clemmons, D. R. AU - Maile, L. A. AU - Ling, Y. PY - 2007 DA - 2007// TI - Role of the integrin alphavbeta3 in mediating increased smooth muscle cell responsiveness to igf-i in response to hyperglycemic stress JO - Growth Horm IGF Res VL - 17 UR - https://doi.org/10.1016/j.ghir.2007.01.004 DO - 10.1016/j.ghir.2007.01.004 ID - Clemmons2007 ER - TY - JOUR AU - Malaguarnera, R. AU - Sacco, A. AU - Morcavallo, A. PY - 2014 DA - 2014// TI - Metformin inhibits androgen-induced igf-ir up-regulation in prostate cancer cells by disrupting membrane-initiated androgen signaling JO - Endocrinology VL - 155 UR - https://doi.org/10.1210/en.2013-1925 DO - 10.1210/en.2013-1925 ID - Malaguarnera2014 ER - TY - JOUR AU - Zakikhani, M. AU - Blouin, M. J. AU - Piura, E. PY - 2010 DA - 2010// TI - Metformin and rapamycin have distinct effects on the akt pathway and proliferation in breast cancer cells JO - Breast Cancer Res Treat VL - 123 UR - https://doi.org/10.1007/s10549-010-0763-9 DO - 10.1007/s10549-010-0763-9 ID - Zakikhani2010 ER - TY - JOUR AU - Ning, J. AU - Clemmons, D. R. PY - 2010 DA - 2010// TI - Amp-activated protein kinase inhibits igf-i signaling and protein synthesis in vascular smooth muscle cells via stimulation of insulin receptor substrate 1 s794 and tuberous sclerosis 2 s1345 phosphorylation JO - Mol Endocrinol VL - 24 UR - https://doi.org/10.1210/me.2009-0474 DO - 10.1210/me.2009-0474 ID - Ning2010 ER - TY - JOUR AU - Karnevi, E. AU - Said, K. AU - Andersson, R. PY - 2013 DA - 2013// TI - Metformin-mediated growth inhibition involves suppression of the igf-i receptor signalling pathway in human pancreatic cancer cells JO - BMC Cancer VL - 13 UR - https://doi.org/10.1186/1471-2407-13-235 DO - 10.1186/1471-2407-13-235 ID - Karnevi2013 ER - TY - JOUR AU - Rozengurt, E. AU - Sinnett-Smith, J. AU - Kisfalvi, K. PY - 2010 DA - 2010// TI - Crosstalk between insulin/insulin-like growth factor-1 receptors and g protein-coupled receptor signaling systems: a novel target for the antidiabetic drug metformin in pancreatic cancer JO - Clin Cancer Res VL - 16 UR - https://doi.org/10.1158/1078-0432.CCR-09-2229 DO - 10.1158/1078-0432.CCR-09-2229 ID - Rozengurt2010 ER - TY - JOUR AU - Kyriakis, J. M. AU - Avruch, J. PY - 2001 DA - 2001// TI - Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation JO - Physiol Rev VL - 81 ID - Kyriakis2001 ER - TY - JOUR AU - McCubrey, J. A. AU - Steelman, L. S. AU - Chappell, W. H. PY - 2007 DA - 2007// TI - Roles of the raf/mek/erk pathway in cell growth, malignant transformation and drug resistance JO - Biochim Biophys Acta VL - 1773 UR - https://doi.org/10.1016/j.bbamcr.2006.10.001 DO - 10.1016/j.bbamcr.2006.10.001 ID - McCubrey2007 ER - TY - JOUR AU - Sharma, A. AU - Tran, M. A. AU - Liang, S. PY - 2006 DA - 2006// TI - Targeting mitogen-activated protein kinase/extracellular signal-regulated kinase kinase in the mutant (v600e) b-raf signaling cascade effectively inhibits melanoma lung metastases JO - Cancer Res VL - 66 UR - https://doi.org/10.1158/0008-5472.CAN-06-0809 DO - 10.1158/0008-5472.CAN-06-0809 ID - Sharma2006 ER - TY - JOUR AU - Panka, D. J. AU - Atkins, M. B. AU - Mier, J. W. PY - 2006 DA - 2006// TI - Targeting the mitogen-activated protein kinase pathway in the treatment of malignant melanoma JO - Clin Cancer Res VL - 12 UR - https://doi.org/10.1158/1078-0432.CCR-05-2539 DO - 10.1158/1078-0432.CCR-05-2539 ID - Panka2006 ER - TY - JOUR AU - Tseng, S. C. AU - Huang, Y. C. AU - Chen, H. J. PY - 2013 DA - 2013// TI - Metformin-mediated downregulation of p38 mitogen-activated protein kinase-dependent excision repair cross-complementing 1 decreases DNA repair capacity and sensitizes human lung cancer cells to paclitaxel JO - Biochem Pharmacol VL - 85 UR - https://doi.org/10.1016/j.bcp.2012.12.001 DO - 10.1016/j.bcp.2012.12.001 ID - Tseng2013 ER - TY - JOUR AU - Hwang, Y. P. AU - Jeong, H. G. PY - 2010 DA - 2010// TI - Metformin blocks migration and invasion of tumour cells by inhibition of matrix metalloproteinase-9 activation through a calcium and protein kinase calpha-dependent pathway: phorbol-12-myristate-13-acetate-induced/extracellular signal-regulated kinase/activator protein-1 JO - Br J Pharmacol VL - 160 UR - https://doi.org/10.1111/j.1476-5381.2010.00762.x DO - 10.1111/j.1476-5381.2010.00762.x ID - Hwang2010 ER - TY - JOUR AU - Liu, B. AU - Fan, Z. AU - Edgerton, S. M. PY - 2009 DA - 2009// TI - Metformin induces unique biological and molecular responses in triple negative breast cancer cells JO - Cell Cycle VL - 8 UR - https://doi.org/10.4161/cc.8.13.8814 DO - 10.4161/cc.8.13.8814 ID - Liu2009 ER - TY - JOUR AU - Alimova, I. N. AU - Liu, B. AU - Fan, Z. PY - 2009 DA - 2009// TI - Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro JO - Cell Cycle VL - 8 UR - https://doi.org/10.4161/cc.8.6.7933 DO - 10.4161/cc.8.6.7933 ID - Alimova2009 ER - TY - JOUR AU - Zordoky, B. N. AU - Bark, D. AU - Soltys, C. L. PY - 2014 DA - 2014// TI - The anti-proliferative effect of metformin in triple-negative mda-mb-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention JO - Biochim Biophys Acta VL - 1840 UR - https://doi.org/10.1016/j.bbagen.2014.01.023 DO - 10.1016/j.bbagen.2014.01.023 ID - Zordoky2014 ER - TY - JOUR AU - Queiroz, E. A. AU - Puukila, S. AU - Eichler, R. PY - 2014 DA - 2014// TI - Metformin induces apoptosis and cell cycle arrest mediated by oxidative stress, ampk and foxo3a in mcf-7 breast cancer cells JO - PLoS ONE VL - 9 UR - https://doi.org/10.1371/journal.pone.0098207 DO - 10.1371/journal.pone.0098207 ID - Queiroz2014 ER - TY - JOUR AU - Monteagudo, S. AU - Perez-Martinez, F. C. AU - Perez-Carrion, M. D. PY - 2012 DA - 2012// TI - Inhibition of p42 mapk using a nonviral vector-delivered sirna potentiates the anti-tumor effect of metformin in prostate cancer cells JO - Nanomedicine (Lond) VL - 7 UR - https://doi.org/10.2217/nnm.11.61 DO - 10.2217/nnm.11.61 ID - Monteagudo2012 ER - TY - JOUR AU - Zhang, Q. AU - Celestino, J. AU - Schmandt, R. PY - 2013 DA - 2013// TI - Chemopreventive effects of metformin on obesity-associated endometrial proliferation JO - Am J Obstet Gynecol VL - 209 UR - https://doi.org/10.1016/j.ajog.2013.03.008 DO - 10.1016/j.ajog.2013.03.008 ID - Zhang2013 ER - TY - JOUR AU - Chaudhary, S. C. AU - Kurundkar, D. AU - Elmets, C. A. PY - 2012 DA - 2012// TI - Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mtor signaling pathway JO - Photochem Photobiol VL - 88 UR - https://doi.org/10.1111/j.1751-1097.2012.01165.x DO - 10.1111/j.1751-1097.2012.01165.x ID - Chaudhary2012 ER - TY - JOUR AU - Wu, N. AU - Gu, C. AU - Gu, H. PY - 2011 DA - 2011// TI - Metformin induces apoptosis of lung cancer cells through activating jnk/p38 mapk pathway and gadd153 JO - Neoplasma VL - 58 UR - https://doi.org/10.4149/neo_2011_06_482 DO - 10.4149/neo_2011_06_482 ID - Wu2011 ER - TY - JOUR AU - Vazquez-Martin, A. AU - Oliveras-Ferraros, C. AU - Menendez, J. A. PY - 2009 DA - 2009// TI - The antidiabetic drug metformin suppresses her2 (erbb-2) oncoprotein overexpression via inhibition of the mtor effector p70s6k1 in human breast carcinoma cells JO - Cell Cycle VL - 8 UR - https://doi.org/10.4161/cc.8.1.7499 DO - 10.4161/cc.8.1.7499 ID - Vazquez-Martin2009 ER - TY - JOUR AU - Vazquez-Martin, A. AU - Oliveras-Ferraros, C. AU - Barco, S. PY - 2011 DA - 2011// TI - The anti-diabetic drug metformin suppresses self-renewal and proliferation of trastuzumab-resistant tumor-initiating breast cancer stem cells JO - Breast Cancer Res Treat VL - 126 UR - https://doi.org/10.1007/s10549-010-0924-x DO - 10.1007/s10549-010-0924-x ID - Vazquez-Martin2011 ER - TY - JOUR AU - Rayet, B. AU - Gelinas, C. PY - 1999 DA - 1999// TI - Aberrant rel/nfkb genes and activity in human cancer JO - Oncogene VL - 18 UR - https://doi.org/10.1038/sj.onc.1203221 DO - 10.1038/sj.onc.1203221 ID - Rayet1999 ER - TY - JOUR AU - Wang, C. Y. AU - Cusack, J. C. AU - Liu, R. PY - 1999 DA - 1999// TI - Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of nf-kappab JO - Nat Med VL - 5 UR - https://doi.org/10.1038/7410 DO - 10.1038/7410 ID - Wang1999 ER - TY - JOUR AU - Jung, M. AU - Dritschilo, A. PY - 2001 DA - 2001// TI - Nf-kappa b signaling pathway as a target for human tumor radiosensitization JO - Semin Radiat Oncol VL - 11 UR - https://doi.org/10.1053/srao.2001.26034 DO - 10.1053/srao.2001.26034 ID - Jung2001 ER - TY - JOUR AU - Aggarwal, B. B. PY - 2004 DA - 2004// TI - Nuclear factor-kappab: the enemy within JO - Cancer Cell VL - 6 UR - https://doi.org/10.1016/j.ccr.2004.09.003 DO - 10.1016/j.ccr.2004.09.003 ID - Aggarwal2004 ER - TY - JOUR AU - Escarcega, R. O. AU - Fuentes-Alexandro, S. AU - Garcia-Carrasco, M. PY - 2007 DA - 2007// TI - The transcription factor nuclear factor-kappa b and cancer JO - Clin Oncol (R Coll Radiol) VL - 19 UR - https://doi.org/10.1016/j.clon.2006.11.013 DO - 10.1016/j.clon.2006.11.013 ID - Escarcega2007 ER - TY - JOUR AU - Zheng, L. AU - Yang, W. AU - Wu, F. PY - 2013 DA - 2013// TI - Prognostic significance of ampk activation and therapeutic effects of metformin in hepatocellular carcinoma JO - Clin Cancer Res VL - 19 UR - https://doi.org/10.1158/1078-0432.CCR-13-0203 DO - 10.1158/1078-0432.CCR-13-0203 ID - Zheng2013 ER - TY - JOUR AU - Reya, T. AU - Morrison, S. J. AU - Clarke, M. F. PY - 2001 DA - 2001// TI - Stem cells, cancer, and cancer stem cells JO - Nature VL - 414 UR - https://doi.org/10.1038/35102167 DO - 10.1038/35102167 ID - Reya2001 ER - TY - JOUR AU - Dalerba, P. AU - Cho, R. W. AU - Clarke, M. F. PY - 2007 DA - 2007// TI - Cancer stem cells: models and concepts JO - Annu Rev Med VL - 58 UR - https://doi.org/10.1146/annurev.med.58.062105.204854 DO - 10.1146/annurev.med.58.062105.204854 ID - Dalerba2007 ER - TY - JOUR AU - Lou, H. AU - Dean, M. PY - 2007 DA - 2007// TI - Targeted therapy for cancer stem cells: the patched pathway and abc transporters JO - Oncogene VL - 26 UR - https://doi.org/10.1038/sj.onc.1210200 DO - 10.1038/sj.onc.1210200 ID - Lou2007 ER - TY - JOUR AU - Ma, S. AU - Lee, T. K. AU - Zheng, B. J. PY - 2008 DA - 2008// TI - Cd133+ hcc cancer stem cells confer chemoresistance by preferential expression of the akt/pkb survival pathway JO - Oncogene VL - 27 UR - https://doi.org/10.1038/sj.onc.1210811 DO - 10.1038/sj.onc.1210811 ID - Ma2008 ER - TY - JOUR AU - Zhou, B. B. AU - Zhang, H. AU - Damelin, M. PY - 2009 DA - 2009// TI - Tumour-initiating cells: challenges and opportunities for anticancer drug discovery JO - Nat Rev Drug Discov VL - 8 UR - https://doi.org/10.1038/nrd2137 DO - 10.1038/nrd2137 ID - Zhou2009 ER - TY - JOUR AU - Frosina, G. PY - 2009 DA - 2009// TI - DNA repair and resistance of gliomas to chemotherapy and radiotherapy JO - Mol Cancer Res VL - 7 UR - https://doi.org/10.1158/1541-7786.MCR-09-0030 DO - 10.1158/1541-7786.MCR-09-0030 ID - Frosina2009 ER - TY - JOUR AU - Bao, S. AU - Wu, Q. AU - McLendon, R. E. PY - 2006 DA - 2006// TI - Glioma stem cells promote radioresistance by preferential activation of the DNA damage response JO - Nature VL - 444 UR - https://doi.org/10.1038/nature05236 DO - 10.1038/nature05236 ID - Bao2006 ER - TY - JOUR AU - Phillips, T. M. AU - McBride, W. H. AU - Pajonk, F. PY - 2006 DA - 2006// TI - The response of cd24(-/low)/cd44+ breast cancer-initiating cells to radiation JO - J Natl Cancer Inst VL - 98 UR - https://doi.org/10.1093/jnci/djj495 DO - 10.1093/jnci/djj495 ID - Phillips2006 ER - TY - JOUR AU - Baumann, M. AU - Krause, M. AU - Hill, R. PY - 2008 DA - 2008// TI - Exploring the role of cancer stem cells in radioresistance JO - Nat Rev Cancer VL - 8 UR - https://doi.org/10.1038/nrc2419 DO - 10.1038/nrc2419 ID - Baumann2008 ER - TY - JOUR AU - Alvero, A. B. AU - Chen, R. AU - Fu, H. H. PY - 2009 DA - 2009// TI - Molecular phenotyping of human ovarian cancer stem cells unravels the mechanisms for repair and chemoresistance JO - Cell Cycle VL - 8 UR - https://doi.org/10.4161/cc.8.1.7533 DO - 10.4161/cc.8.1.7533 ID - Alvero2009 ER - TY - JOUR AU - Hirsch, H. A. AU - Iliopoulos, D. AU - Tsichlis, P. N. PY - 2009 DA - 2009// TI - Metformin selectively targets cancer stem cells, and acts together with chemotherapy to block tumor growth and prolong remission JO - Cancer Res VL - 69 UR - https://doi.org/10.1158/0008-5472.CAN-09-2994 DO - 10.1158/0008-5472.CAN-09-2994 ID - Hirsch2009 ER - TY - JOUR AU - Iliopoulos, D. AU - Hirsch, H. A. AU - Struhl, K. PY - 2011 DA - 2011// TI - Metformin decreases the dose of chemotherapy for prolonging tumor remission in mouse xenografts involving multiple cancer cell types JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-3471 DO - 10.1158/0008-5472.CAN-10-3471 ID - Iliopoulos2011 ER - TY - JOUR AU - Bao, B. AU - Wang, Z. AU - Ali, S. PY - 2012 DA - 2012// TI - Metformin inhibits cell proliferation, migration and invasion by attenuating csc function mediated by deregulating mirnas in pancreatic cancer cells JO - Cancer Prev Res (Phila) VL - 5 UR - https://doi.org/10.1158/1940-6207.CAPR-11-0299 DO - 10.1158/1940-6207.CAPR-11-0299 ID - Bao2012 ER - TY - JOUR AU - Mohammed, A. AU - Janakiram, N. B. AU - Brewer, M. PY - 2013 DA - 2013// TI - Antidiabetic drug metformin prevents progression of pancreatic cancer by targeting in part cancer stem cells and mtor signaling JO - Transl Oncol VL - 6 UR - https://doi.org/10.1593/tlo.13556 DO - 10.1593/tlo.13556 ID - Mohammed2013 ER - TY - JOUR AU - Honjo, S. AU - Ajani, J. A. AU - Scott, A. W. PY - 2014 DA - 2014// TI - Metformin sensitizes chemotherapy by targeting cancer stem cells and the mtor pathway in esophageal cancer JO - Int J Oncol VL - 45 ID - Honjo2014 ER - TY - JOUR AU - Vazquez-Martin, A. AU - Oliveras-Ferraros, C. AU - Cufi, S. PY - 2011 DA - 2011// TI - The anti-diabetic drug metformin suppresses the metastasis-associated protein cd24 in mda-mb-468 triple-negative breast cancer cells JO - Oncol Rep VL - 25 ID - Vazquez-Martin2011 ER - TY - JOUR AU - Song, C. W. AU - Lee, H. AU - Dings, R. P. PY - 2012 DA - 2012// TI - Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells JO - Sci Rep VL - 2 ID - Song2012 ER - TY - JOUR AU - Hirsch, H. A. AU - Iliopoulos, D. AU - Struhl, K. PY - 2013 DA - 2013// TI - Metformin inhibits the inflammatory response associated with cellular transformation and cancer stem cell growth JO - Proc Natl Acad Sci USA VL - 110 UR - https://doi.org/10.1073/pnas.1221055110 DO - 10.1073/pnas.1221055110 ID - Hirsch2013 ER -